W.R. Berkley Corp’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

W.R. Berkley Corp’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-406,062	Closed	-$4.17M	–	300
2022 Q4	$4.17M	Hold	406,062	–	–	0.23%	77
2022 Q3	$4.09M	Hold	406,062	–	–	0.2%	93
2022 Q2	$4.07M	Hold	406,062	–	–	0.2%	93
2022 Q1	$4.06M	Hold	406,062	–	–	0.21%	100
2021 Q4	$4.02M	Buy	+406,062	New	+$4.01M	0.22%	100

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

W.R. Berkley Corp's IQMD Position: Q1 2023 in Review

W.R. Berkley Corp sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 406,062 shares — an estimated $4.17M sold.

W.R. Berkley Corp first reported a position in IQMD in Q4 2021 and held it in 5 quarters. The position peaked at $4.17M in Q4 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

W.R. Berkley Corp reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
W.R. Berkley Corp sold 406,062 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $4.17M.
W.R. Berkley Corp first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 5 quarters.
W.R. Berkley Corp's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $4.17M in Q4 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on W.R. Berkley Corp's 13F filing for Q1 2023, filed 15 May 2023.